Literature DB >> 28759861

Concurrent hyperadrenocorticism and diabetes mellitus in dogs.

D D Miceli1, O P Pignataro2, V A Castillo3.   

Abstract

Hyperadrenocorticism (HAC) and diabetes mellitus (DM) are two diseases that can occur concurrently in dogs. The objective of this study was to evaluate the coexistence of HAC and DM, and the risk factors involved that could contribute to the development of DM in dogs with HAC. A total of 235 dogs with HAC were studied and, according to their fasting glycemia, they were divided into three groups: <5.6mmol/L, between 5.6 and 10.08mmol/L and >10.08mmol/L. The following parameters were evaluated: age, gender, cause of HAC, body condition, glycemia, total cholesterol, triglycerides, urinary cortisol:creatinin ratio (UCCR) and survival time. A 13.61% concurrence of HAC and DM was observed. Dogs with a fasting glycemia >5.6mmol/L, with dislipemia, with Pituitary-Dependent Hyperadrenocorticism, UCCR >100×10-6 and non-castrated females showed a higher risk of developing DM. The development of DM in dogs with HAC reduces the survival time.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Hyperadrenocorticism; Hypercortisolism; Insulin resistance

Mesh:

Substances:

Year:  2017        PMID: 28759861     DOI: 10.1016/j.rvsc.2017.07.026

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  10 in total

1.  Emphysematous cystitis: Retrospective evaluation of predisposing factors and ultrasound features in 36 dogs and 2 cats.

Authors:  Ilaria Lippi; Tommaso Mannucci; Daniele Della Santa; Gabriele Barella; Martina Oranges; Simonetta Citi
Journal:  Can Vet J       Date:  2019-05       Impact factor: 1.008

2.  Frequency and risk factors for naturally occurring Cushing's syndrome in dogs attending UK primary-care practices.

Authors:  I Schofield; D C Brodbelt; S J M Niessen; D B Church; R F Geddes; D G O'Neill
Journal:  J Small Anim Pract       Date:  2021-12-08       Impact factor: 1.669

3.  Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism.

Authors:  Diego Daniel Miceli; Patricia Noemi Vidal; María Fernanda Cabrera Batter; Omar Pignataro; Victor Alejandro Castillo
Journal:  Open Vet J       Date:  2018-05-30

Review 4.  Comparative occurrence of diabetes in canine, feline, and few wild animals and their association with pancreatic diseases and ketoacidosis with therapeutic approach.

Authors:  Kamal Niaz; Faheem Maqbool; Fazlullah Khan; Fatima Ismail Hassan; Saeideh Momtaz; Mohammad Abdollahi
Journal:  Vet World       Date:  2018-04-05

5.  Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism.

Authors:  Paula García San José; Carolina Arenas Bermejo; Irene Clares Moral; Pedro Cuesta Alvaro; María Dolores Pérez Alenza
Journal:  J Vet Intern Med       Date:  2020-07-02       Impact factor: 3.333

6.  Machine-learning based prediction of Cushing's syndrome in dogs attending UK primary-care veterinary practice.

Authors:  Imogen Schofield; David C Brodbelt; Noel Kennedy; Stijn J M Niessen; David B Church; Rebecca F Geddes; Dan G O'Neill
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

7.  The odds of neoplasia in dogs with and without diabetes mellitus.

Authors:  Sindumani A Manoharan; Rebecka S Hess
Journal:  J Vet Intern Med       Date:  2022-01-26       Impact factor: 3.333

8.  Overexpression of 11β-hydroxysteroid dehydrogenase 1 in visceral adipose tissue and underexpression of endothelial nitric oxide synthase in the adrenal cortex of dogs with hyperadrenocorticism.

Authors:  Diego Daniel Miceli; Adriana María Belén Abiuso; Patricia Noemi Vidal; María Florencia Gallelli; Omar Pedro Pignataro; Victor Alejandro Castillo
Journal:  Open Vet J       Date:  2018-03-18

9.  Survival analysis of 219 dogs with hyperadrenocorticism attending primary care practice in England.

Authors:  Imogen Schofield; David C Brodbelt; Anna R L Wilson; Stijn Niessen; David Church; Dan O'Neill
Journal:  Vet Rec       Date:  2019-09-20       Impact factor: 2.695

10.  Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment.

Authors:  Diego D Miceli; Gabriela S Zelarayán; Jorge D García; Viviana Fernández; Sergio Ferraris
Journal:  JFMS Open Rep       Date:  2021-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.